Physician profile
Brian M Sadowski
NPI 1841464443
$3,094.97
in general payments reported to CMS, 2019-2025
62 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $308 · 2021: $445 · 2022: $616 · 2023: $333 · 2024: $685 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,492.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $228.64 | 2019-2025 | Keytruda, Lynparza |
| Medtronic, INC. | $227.43 | 2022-2025 | Interstim |
| Conmed Corporation | $180.80 | 2021-2022 | |
| Eisai INC. | $153.66 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $151.31 | 2020-2025 | Calquence |
| Medtronic USA, INC. | $144.47 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.30 | 2019-2024 | Xifaxan |
| Ferring Pharmaceuticals INC. | $95.19 | 2019-2025 | Rebyota |
| Seagen INC. | $85.69 | 2020-2022 | |
| Janssen Biotech, INC. | $83.31 | 2019-2025 | Erleada |
| Intuitive Surgical, INC. | $78.26 | 2022 | |
| Daiichi Sankyo INC. | $70.23 | 2020-2024 | Enhertu |
| Smith+Nephew, INC. | $68.00 | 2023-2024 | Collagenase Santyl, Grafix Pl, Stravix |
| Bayer Healthcare Pharmaceuticals INC. | $67.21 | 2022-2025 | |
| Celgene Corporation | $59.35 | 2024-2025 | Reblozyl |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sadowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.